HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michiel S Van Der Heijden Selected Research
Michiel S Van Der Heijden Research Topics
Disease
5
Carcinoma (Carcinomatosis)
12/2023 - 11/2019
5
Neoplasms (Cancer)
10/2022 - 11/2019
3
Urinary Bladder Neoplasms (Bladder Cancer)
10/2022 - 01/2021
2
Disease Progression
01/2022 - 01/2021
1
Tertiary Lymphoid Structures
10/2022
1
Infections
10/2022
1
Fatigue
01/2021
1
Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2021
1
Head and Neck Neoplasms (Head and Neck Cancer)
06/2004
Drug/Important Bio-Agent (IBA)
7
atezolizumab
IBA
12/2023 - 11/2019
4
Biomarkers (Surrogate Marker)
IBA
12/2023 - 11/2019
2
Immune Checkpoint Inhibitors
IBA
10/2022 - 09/2021
2
Cisplatin (Platino)
FDA Link
Generic
01/2022 - 01/2021
2
B7-H1 Antigen
IBA
01/2021 - 01/2021
1
Chemokines
IBA
10/2022
1
pembrolizumab
IBA
10/2022
1
Transaminases (Aminotransferases)
IBA
01/2021
1
Nivolumab
IBA
01/2021
1
bempegaldesleukin
IBA
01/2021
1
Tumor Biomarkers (Tumor Markers)
IBA
11/2019
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
06/2004
Therapy/Procedure
3
Cystectomy
01/2022 - 11/2019
2
Therapeutics
09/2021 - 01/2021
1
Immunomodulation
10/2022
1
Immunotherapy
01/2022
1
Drug Therapy (Chemotherapy)
01/2021
1
Aftercare (After-Treatment)
11/2019